Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of CJ-12420 in Erosive Esophagitis
NCT03006874Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- May 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in erosive esophagitis (EE), sponsored by HK inno.N Corporation. Started May 2016; status: completed.
02
Drugs
tegoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT03006874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006874.